United States Nanostructured Drug Market Report & Forecast 2021-2027

Publisher Name :
Date: 11-Oct-2021
No. of pages: 114
Inquire Before Buying

United States Nanostructured Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

United States Nanostructured Drug Market Segment Percentages, By Type, 2020 (%)

- Liposomes

- Polymeric Micelles

- Solid lipid Nanoparticles

- Microemulsion and Nanoemulsion

- Nanosuspension

United States Nanostructured Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

United States Nanostructured Drug Market Segment Percentages, By Application, 2020 (%)

- Cancer and Tumors

- Autoimmune Disorders

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nanostructured Drug revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Nanostructured Drug revenues share in United States market, 2020 (%)

Key companies Nanostructured Drug sales in United States market, 2016-2021 (Estimated), (K MT)

Key companies Nanostructured Drug sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Merck

- Pfizer

- Novartis

- Abbott

- GlaxoSmithKline

- Roche

- Sanofi

- Eli Lilly

- Astrazeneca

- Johnson & Johnson

- Celgene

- Novavax

- Stryker

- Gilead Sciences

- OSI Pharmaceuticals

- Kadmon Pharmaceuticals

- Samyang Biopharm

- Mitsubishi Pharma

- Kaken Pharmaceutical

- Selecta Biosciences

- Par Pharmaceutical

- Cerulean Pharma

- Navidea Biopharmaceuticals

- Lummy

United States Nanostructured Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nanostructured Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Nanostructured Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Nanostructured Drug Overall Market Size
2.1 United States Nanostructured Drug Market Size: 2021 VS 2027
2.2 United States Nanostructured Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Nanostructured Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Nanostructured Drug Players in United States Market
3.2 Top United States Nanostructured Drug Companies Ranked by Revenue
3.3 United States Nanostructured Drug Revenue by Companies
3.4 United States Nanostructured Drug Sales by Companies
3.5 United States Nanostructured Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nanostructured Drug Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Nanostructured Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nanostructured Drug Players in United States Market
3.8.1 List of Tier 1 Nanostructured Drug Companies in United States
3.8.2 List of Tier 2 and Tier 3 Nanostructured Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Nanostructured Drug Market Size Markets, 2021 & 2027
4.1.2 Liposomes
4.1.3 Polymeric Micelles
4.1.4 Solid lipid Nanoparticles
4.1.5 Microemulsion and Nanoemulsion
4.1.6 Nanosuspension
4.2 By Type - United States Nanostructured Drug Revenue & Forecasts
4.2.1 By Type - United States Nanostructured Drug Revenue, 2016-2021
4.2.2 By Type - United States Nanostructured Drug Revenue, 2022-2027
4.2.3 By Type - United States Nanostructured Drug Revenue Market Share, 2016-2027
4.3 By Type - United States Nanostructured Drug Sales & Forecasts
4.3.1 By Type - United States Nanostructured Drug Sales, 2016-2021
4.3.2 By Type - United States Nanostructured Drug Sales, 2022-2027
4.3.3 By Type - United States Nanostructured Drug Sales Market Share, 2016-2027
4.4 By Type - United States Nanostructured Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Nanostructured Drug Market Size, 2021 & 2027
5.1.2 Cancer and Tumors
5.1.3 Autoimmune Disorders
5.2 By Application - United States Nanostructured Drug Revenue & Forecasts
5.2.1 By Application - United States Nanostructured Drug Revenue, 2016-2021
5.2.2 By Application - United States Nanostructured Drug Revenue, 2022-2027
5.2.3 By Application - United States Nanostructured Drug Revenue Market Share, 2016-2027
5.3 By Application - United States Nanostructured Drug Sales & Forecasts
5.3.1 By Application - United States Nanostructured Drug Sales, 2016-2021
5.3.2 By Application - United States Nanostructured Drug Sales, 2022-2027
5.3.3 By Application - United States Nanostructured Drug Sales Market Share, 2016-2027
5.4 By Application - United States Nanostructured Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Overview
6.1.3 Merck Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.1.4 Merck Nanostructured Drug Product Description
6.1.5 Merck Recent Developments
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Overview
6.2.3 Pfizer Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.2.4 Pfizer Nanostructured Drug Product Description
6.2.5 Pfizer Recent Developments
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Overview
6.3.3 Novartis Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.3.4 Novartis Nanostructured Drug Product Description
6.3.5 Novartis Recent Developments
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Overview
6.4.3 Abbott Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.4.4 Abbott Nanostructured Drug Product Description
6.4.5 Abbott Recent Developments
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Overview
6.5.3 GlaxoSmithKline Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.5.4 GlaxoSmithKline Nanostructured Drug Product Description
6.5.5 GlaxoSmithKline Recent Developments
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Overview
6.6.3 Roche Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.6.4 Roche Nanostructured Drug Product Description
6.6.5 Roche Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.7.4 Sanofi Nanostructured Drug Product Description
6.7.5 Sanofi Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Overview
6.8.3 Eli Lilly Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.8.4 Eli Lilly Nanostructured Drug Product Description
6.8.5 Eli Lilly Recent Developments
6.9 Astrazeneca
6.9.1 Astrazeneca Corporation Information
6.9.2 Astrazeneca Overview
6.9.3 Astrazeneca Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.9.4 Astrazeneca Nanostructured Drug Product Description
6.9.5 Astrazeneca Recent Developments
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Overview
6.10.3 Johnson & Johnson Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.10.4 Johnson & Johnson Nanostructured Drug Product Description
6.10.5 Johnson & Johnson Recent Developments
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Overview
6.11.3 Celgene Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.11.4 Celgene Nanostructured Drug Product Description
6.11.5 Celgene Recent Developments
6.12 Novavax
6.12.1 Novavax Corporation Information
6.12.2 Novavax Overview
6.12.3 Novavax Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.12.4 Novavax Nanostructured Drug Product Description
6.12.5 Novavax Recent Developments
6.13 Stryker
6.13.1 Stryker Corporation Information
6.13.2 Stryker Overview
6.13.3 Stryker Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.13.4 Stryker Nanostructured Drug Product Description
6.13.5 Stryker Recent Developments
6.14 Gilead Sciences
6.14.1 Gilead Sciences Corporation Information
6.14.2 Gilead Sciences Overview
6.14.3 Gilead Sciences Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.14.4 Gilead Sciences Nanostructured Drug Product Description
6.14.5 Gilead Sciences Recent Developments
6.15 OSI Pharmaceuticals
6.15.1 OSI Pharmaceuticals Corporation Information
6.15.2 OSI Pharmaceuticals Overview
6.15.3 OSI Pharmaceuticals Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.15.4 OSI Pharmaceuticals Nanostructured Drug Product Description
6.15.5 OSI Pharmaceuticals Recent Developments
6.16 Kadmon Pharmaceuticals
6.16.1 Kadmon Pharmaceuticals Corporation Information
6.16.2 Kadmon Pharmaceuticals Overview
6.16.3 Kadmon Pharmaceuticals Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.16.4 Kadmon Pharmaceuticals Nanostructured Drug Product Description
6.16.5 Kadmon Pharmaceuticals Recent Developments
6.17 Samyang Biopharm
6.17.1 Samyang Biopharm Corporation Information
6.17.2 Samyang Biopharm Overview
6.17.3 Samyang Biopharm Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.17.4 Samyang Biopharm Nanostructured Drug Product Description
6.17.5 Samyang Biopharm Recent Developments
6.18 Mitsubishi Pharma
6.18.1 Mitsubishi Pharma Corporation Information
6.18.2 Mitsubishi Pharma Overview
6.18.3 Mitsubishi Pharma Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.18.4 Mitsubishi Pharma Nanostructured Drug Product Description
6.18.5 Mitsubishi Pharma Recent Developments
6.19 Kaken Pharmaceutical
6.19.1 Kaken Pharmaceutical Corporation Information
6.19.2 Kaken Pharmaceutical Overview
6.19.3 Kaken Pharmaceutical Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.19.4 Kaken Pharmaceutical Nanostructured Drug Product Description
6.19.5 Kaken Pharmaceutical Recent Developments
6.20 Selecta Biosciences
6.20.1 Selecta Biosciences Corporation Information
6.20.2 Selecta Biosciences Overview
6.20.3 Selecta Biosciences Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.20.4 Selecta Biosciences Nanostructured Drug Product Description
6.20.5 Selecta Biosciences Recent Developments
6.21 Par Pharmaceutical
6.21.1 Par Pharmaceutical Corporation Information
6.21.2 Par Pharmaceutical Overview
6.21.3 Par Pharmaceutical Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.21.4 Par Pharmaceutical Nanostructured Drug Product Description
6.21.5 Par Pharmaceutical Recent Developments
6.22 Cerulean Pharma
6.22.1 Cerulean Pharma Corporation Information
6.22.2 Cerulean Pharma Overview
6.22.3 Cerulean Pharma Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.22.4 Cerulean Pharma Nanostructured Drug Product Description
6.22.5 Cerulean Pharma Recent Developments
6.23 Navidea Biopharmaceuticals
6.23.1 Navidea Biopharmaceuticals Corporation Information
6.23.2 Navidea Biopharmaceuticals Overview
6.23.3 Navidea Biopharmaceuticals Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.23.4 Navidea Biopharmaceuticals Nanostructured Drug Product Description
6.23.5 Navidea Biopharmaceuticals Recent Developments
6.24 Lummy
6.24.1 Lummy Corporation Information
6.24.2 Lummy Overview
6.24.3 Lummy Nanostructured Drug Sales and Revenue in United States Market (2016-2021)
6.24.4 Lummy Nanostructured Drug Product Description
6.24.5 Lummy Recent Developments
7 United States Nanostructured Drug Production Capacity, Analysis
7.1 United States Nanostructured Drug Production Capacity, 2016-2027
7.2 Nanostructured Drug Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Nanostructured Drug Supply Chain Analysis
9.1 Nanostructured Drug Industry Value Chain
9.2 Nanostructured Drug Upstream Market
9.3 Nanostructured Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Nanostructured Drug Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Nanostructured Drug in United States Market
Table 2. Top Nanostructured Drug Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Nanostructured Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Nanostructured Drug Revenue Share by Companies, 2016-2021
Table 5. United States Nanostructured Drug Sales by Companies, (K MT), 2016-2021
Table 6. United States Nanostructured Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nanostructured Drug Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Nanostructured Drug Product Type
Table 9. List of Tier 1 Nanostructured Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Nanostructured Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Liposomes
Table 12. Major Manufacturers of Polymeric Micelles
Table 13. By Type - United States Nanostructured Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Nanostructured Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Nanostructured Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Nanostructured Drug Sales (K MT), 2016-2021
Table 17. By Type - United States Nanostructured Drug Sales (K MT), 2022-2027
Table 18. By Application - United States Nanostructured Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Nanostructured Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Nanostructured Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Nanostructured Drug Sales (K MT), 2016-2021
Table 22. By Application - United States Nanostructured Drug Sales (K MT), 2022-2027
Table 23. Merck Corporation Information
Table 24. Merck Description and Major Businesses
Table 25. Merck Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Merck Nanostructured Drug Product
Table 27. Merck Recent Developments
Table 28. Pfizer Corporation Information
Table 29. Pfizer Description and Major Businesses
Table 30. Pfizer Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Pfizer Nanostructured Drug Product
Table 32. Pfizer Recent Developments
Table 33. Novartis Corporation Information
Table 34. Novartis Description and Major Businesses
Table 35. Novartis Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Novartis Nanostructured Drug Product
Table 37. Novartis Recent Developments
Table 38. Abbott Corporation Information
Table 39. Abbott Description and Major Businesses
Table 40. Abbott Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Abbott Nanostructured Drug Product
Table 42. Abbott Recent Developments
Table 43. GlaxoSmithKline Corporation Information
Table 44. GlaxoSmithKline Description and Major Businesses
Table 45. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. GlaxoSmithKline Nanostructured Drug Product
Table 47. GlaxoSmithKline Recent Developments
Table 48. Roche Corporation Information
Table 49. Roche Description and Major Businesses
Table 50. Roche Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Roche Nanostructured Drug Product
Table 52. Roche Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Sanofi Nanostructured Drug Product
Table 57. Sanofi Recent Developments
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Major Businesses
Table 60. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Eli Lilly Nanostructured Drug Product
Table 62. Eli Lilly Recent Developments
Table 63. Astrazeneca Corporation Information
Table 64. Astrazeneca Description and Major Businesses
Table 65. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. Astrazeneca Nanostructured Drug Product
Table 67. Astrazeneca Recent Developments
Table 68. Johnson & Johnson Corporation Information
Table 69. Johnson & Johnson Description and Major Businesses
Table 70. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 71. Johnson & Johnson Nanostructured Drug Product
Table 72. Johnson & Johnson Recent Developments
Table 73. Celgene Corporation Information
Table 74. Celgene Description and Major Businesses
Table 75. Celgene Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 76. Celgene Nanostructured Drug Product
Table 77. Celgene Recent Developments
Table 78. Novavax Corporation Information
Table 79. Novavax Description and Major Businesses
Table 80. Novavax Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 81. Novavax Nanostructured Drug Product
Table 82. Novavax Recent Developments
Table 83. Stryker Corporation Information
Table 84. Stryker Description and Major Businesses
Table 85. Stryker Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 86. Stryker Nanostructured Drug Product
Table 87. Stryker Recent Developments
Table 88. Gilead Sciences Corporation Information
Table 89. Gilead Sciences Description and Major Businesses
Table 90. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 91. Gilead Sciences Nanostructured Drug Product
Table 92. Gilead Sciences Recent Developments
Table 93. OSI Pharmaceuticals Corporation Information
Table 94. OSI Pharmaceuticals Description and Major Businesses
Table 95. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 96. OSI Pharmaceuticals Nanostructured Drug Product
Table 97. OSI Pharmaceuticals Recent Developments
Table 98. Kadmon Pharmaceuticals Corporation Information
Table 99. Kadmon Pharmaceuticals Description and Major Businesses
Table 100. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 101. Kadmon Pharmaceuticals Nanostructured Drug Product
Table 102. Kadmon Pharmaceuticals Recent Developments
Table 103. Samyang Biopharm Corporation Information
Table 104. Samyang Biopharm Description and Major Businesses
Table 105. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 106. Samyang Biopharm Nanostructured Drug Product
Table 107. Samyang Biopharm Recent Developments
Table 108. Mitsubishi Pharma Corporation Information
Table 109. Mitsubishi Pharma Description and Major Businesses
Table 110. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 111. Mitsubishi Pharma Nanostructured Drug Product
Table 112. Mitsubishi Pharma Recent Developments
Table 113. Kaken Pharmaceutical Corporation Information
Table 114. Kaken Pharmaceutical Description and Major Businesses
Table 115. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 116. Kaken Pharmaceutical Nanostructured Drug Product
Table 117. Kaken Pharmaceutical Recent Developments
Table 118. Selecta Biosciences Corporation Information
Table 119. Selecta Biosciences Description and Major Businesses
Table 120. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 121. Selecta Biosciences Nanostructured Drug Product
Table 122. Selecta Biosciences Recent Developments
Table 123. Par Pharmaceutical Corporation Information
Table 124. Par Pharmaceutical Description and Major Businesses
Table 125. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 126. Par Pharmaceutical Nanostructured Drug Product
Table 127. Par Pharmaceutical Recent Developments
Table 128. Cerulean Pharma Corporation Information
Table 129. Cerulean Pharma Description and Major Businesses
Table 130. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 131. Cerulean Pharma Nanostructured Drug Product
Table 132. Cerulean Pharma Recent Developments
Table 133. Navidea Biopharmaceuticals Corporation Information
Table 134. Navidea Biopharmaceuticals Description and Major Businesses
Table 135. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 136. Navidea Biopharmaceuticals Nanostructured Drug Product
Table 137. Navidea Biopharmaceuticals Recent Developments
Table 138. Lummy Corporation Information
Table 139. Lummy Description and Major Businesses
Table 140. Lummy Nanostructured Drug Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 141. Lummy Nanostructured Drug Product
Table 142. Lummy Recent Developments
Table 143. Nanostructured Drug Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT)
Table 144. United States Nanostructured Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 145. Nanostructured Drug Market Opportunities & Trends in United States Market
Table 146. Nanostructured Drug Market Drivers in United States Market
Table 147. Nanostructured Drug Market Restraints in United States Market
Table 148. Nanostructured Drug Raw Materials
Table 149. Nanostructured Drug Raw Materials Suppliers in United States Market
Table 150. Typical Nanostructured Drug Downstream
Table 151. Nanostructured Drug Downstream Clients in United States Market
Table 152. Nanostructured Drug Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Nanostructured Drug Product Picture
Figure 2. Nanostructured Drug Segment by Type
Figure 3. Nanostructured Drug Segment by Application
Figure 4. United States Nanostructured Drug Market Overview: 2020
Figure 5. United States Nanostructured Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Nanostructured Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Nanostructured Drug Sales in United States Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Nanostructured Drug Revenue in 2020
Figure 9. Liposomes Product Picture
Figure 10. Polymeric Micelles Product Picture
Figure 11. Solid lipid Nanoparticles Product Picture
Figure 12. Microemulsion and Nanoemulsion Product Picture
Figure 13. Nanosuspension Product Picture
Figure 14. By Type - United States Nanostructured Drug Sales Market Share, 2016-2027
Figure 15. By Type - United States Nanostructured Drug Revenue Market Share, 2016-2027
Figure 16. By Type - United States Nanostructured Drug Price (USD/MT), 2016-2027
Figure 17. Cancer and Tumors
Figure 18. Autoimmune Disorders
Figure 19. By Application - United States Nanostructured Drug Sales Market Share, 2016-2027
Figure 20. By Application - United States Nanostructured Drug Revenue Market Share, 2016-2027
Figure 21. By Application - United States Nanostructured Drug Price (USD/MT), 2016-2027
Figure 22. Merck Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Pfizer Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Novartis Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Abbott Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. GlaxoSmithKline Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Roche Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Sanofi Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Eli Lilly Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Astrazeneca Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Johnson & Johnson Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Celgene Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Novavax Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Stryker Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Gilead Sciences Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. OSI Pharmaceuticals Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Kadmon Pharmaceuticals Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Samyang Biopharm Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Mitsubishi Pharma Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Kaken Pharmaceutical Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Selecta Biosciences Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Par Pharmaceutical Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Cerulean Pharma Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Navidea Biopharmaceuticals Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Lummy Nanostructured Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. United States Nanostructured Drug Production Capacity (K MT), 2016-2027
Figure 47. Nanostructured Drug Industry Value Chain
Figure 48. Marketing Channels
  • Global and Japan Hard HPMC Capsule Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 131
    Hard HPMC Capsule market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hard HPMC Capsule market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Hard HPMC Capsule mar......
  • Global and China Adult Condom Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 160
    Adult Condom market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Adult Condom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Adult Condom market size by pla......
  • Global and United States Pregnancy Point of Care Testing Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 159
    Pregnancy Point of Care Testing market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pregnancy Point of Care Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report ......
  • Global and Japan Notoginseng Root Extract Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 139
    Notoginseng Root Extract market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Notoginseng Root Extract market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Notogin......
  • Global and United States Antidiuretic Hormone (ADH) Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 134
    Antidiuretic Hormone (ADH) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antidiuretic Hormone (ADH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on......
  • Global and China Algae Supplements Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 131
    Algae Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Algae Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Algae Supplements mar......
  • Global and United States Folinic Acid Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 131
    Folinic Acid market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Folinic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Folinic Acid market siz......
  • Global and United States Antiallergic Non-Drug Supplements Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 144
    Antiallergic Non-Drug Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antiallergic Non-Drug Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this rep......
  • Global and United States Eye Drop Bottle Squeezer Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 130
    Eye Drop Bottle Squeezer market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Eye Drop Bottle Squeezer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs